Caris Life Sciences
CAI
Performance
About Caris Life Sciences
Caris Life Sciences is a leading precision medicine company focused on oncology. It provides molecular profiling, including tissue-based and blood-based cancer diagnostics, and leverages multimodal data and AI-powered interpretations to guide personalized cancer treatment for patients, physicians, and biopharma partners globally.
Recent News
Beyond Consumer Use, Wearables May Be at a Clinical Turning Point
Changemaker Draws Leadership Inspiration From HIMSS Membership
JPM 2026: What’s the Outlook Like This Year?
Caris Life Sciences Launches AI Test to Predict Early and Late Breast Cancer Recurrence
AI Uncovers Significant Misdiagnoses in Carcinoma Type, Study Shows
Caris Life Sciences Secures MolDX Approval for Ultra-Deep Myeloid Cancer Sequencing Test
Digital Health and HealthTech IPO Performances in the Last 12 Months: Tempus AI, Waystar, Caris Life Sciences, Hinge Health, Omada Health, Kestra Medical
Recent Deals
No recent deals for this company.